Q3 FY2021 · Interim report
30 pages
Read Novo Nordisk A/S Class B's results firsthand
Preview the first 2 pages of this interim report
Create a free account to start reading
Full documents are included with Professional
Novo Nordisk A/S Class B
42.18
USD
+1.99
(+4.95%)
